In brief
Last year, we warned that the Federal Trade Commission was starting to go after directors, owners and private equity firms in control of entities that violated American antitrust laws. That has now proven true.
On 21 September, the FTC filed a 106-page complaint in the US District Court for the Southern District of Texas against US Anesthesia Partners Inc. and its private equity investor, Welsh Carson Anderson & Stowe XI LP.
In this article, originally published in Law360, Baker McKenzie attorneys delve into the complaint and its potential impacts, including acting as an early test of the newly proposed draft merger guidelines where the FTC and the Antitrust Division of the DOJ.